Aberrant Splicing and Drug Resistance in AML

Journal of Hematology and Oncology - United Kingdom
doi 10.1186/s13045-016-0315-9
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Drug Discovery for Genetic Diseases Caused by Aberrant mRNA Splicing

Proceedings for Annual Meeting of The Japanese Pharmacological Society
2020English

The Clinical Relevance of Cellular Drug Resistance Testing in Childhood Acute Myeloid Leukemia (AML)

Pediatric Research
Child HealthPediatricsPerinatology
1999English

Aberrant RNA Splicing and Mutations in Spliceosome Complex in Acute Myeloid Leukemia

Stem Cell Investigation
2017English

Fatty Acid-Binding Protein FABP4 Mechanistically Links Obesity With Aggressive AML by Enhancing Aberrant DNA Methylation in AML Cells

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2016English

ATP7A and Drug Resistance and Clinical Drug Resistance

Cancer Research
Cancer ResearchOncology
2007English

Apoptosis Repressor With Caspase Recruitment Domain Is Regulated by MAPK/PI3K and Confers Drug Resistance and Survival Advantage to AML

Apoptosis : an international journal on programmed cell death
Cell BiologyPharmacologyBiochemistryClinical BiochemistryCancer ResearchPharmaceutical Science
2013English

The Prognostic Significance of Global Aberrant Alternative Splicing in Patients With Myelodysplastic Syndrome

Blood Cancer Journal
OncologyHematology
2018English

Aberrant Inflammation and Resistance to Glucocorticoids in Annexin 1-/- Mouse

FASEB Journal
BiochemistryBiotechnologyGeneticsMolecular BiologyMedicine
2002English

Mammalian Tissues Defective in Nonsense-Mediated mRNA Decay Display Highly Aberrant Splicing Patterns

Genome Biology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy